Ajanta Pharma Limited
Stock Forecast, Prediction & Price Target

Ajanta Pharma Limited Financial Estimates

Ajanta Pharma Limited Revenue Estimates

Ajanta Pharma Limited EBITDA Estimates

Ajanta Pharma Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
₹28.47B
 
N/A
₹32.84B
 
15.35%
₹42.08B
 
28.15%
Avg: ₹52.96B
Low: ₹52.96B
High: ₹52.96B
avg. 25.83%
Avg: ₹54.81B
Low: ₹54.81B
High: ₹54.81B
avg. 3.49%
Net Income
 
% change YoY
₹6.53B
 
N/A
₹7.12B
 
8.99%
₹8.16B
 
14.52%
Avg: ₹11.08B
Low: ₹9.49B
High: ₹12.04B
avg. 35.80%
Avg: ₹10.59B
Low: ₹10.59B
High: ₹10.59B
avg. -4.45%
EBITDA
 
% change YoY
₹10.24B
 
N/A
₹10.23B
 
-0.05%
₹12.56B
 
22.77%
Avg: ₹15.82B
Low: ₹15.82B
High: ₹15.82B
avg. 25.92%
Avg: ₹16.37B
Low: ₹16.37B
High: ₹16.37B
avg. 3.49%
EPS
 
% change YoY
$50.06
 
N/A
$54.97
 
9.80%
$64.82
 
17.91%
Avg: $87.67
Low: $75.4
High: $95.6
avg. 35.25%
Avg: $84.1
Low: $84.1
High: $84.1
avg. -4.07%
Operating Expenses
 
% change YoY
₹12.72B
 
N/A
₹15.85B
 
24.61%
₹11.19B
 
-29.36%
Avg: ₹6.55B
Low: ₹6.55B
High: ₹6.55B
avg. -41.48%
Avg: ₹6.78B
Low: ₹6.78B
High: ₹6.78B
avg. 3.49%

FAQ

What is Ajanta Pharma Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 15.67% in 2026-2027.

We have gathered data from 10 analysts. Their low estimate is 9.49B, average is 11.08B and high is 12.04B.

What is Ajanta Pharma Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 14.66% in 2026-2027.

We have gathered data from 10 analysts. Their low revenue estimate is ₹52.96B, average is ₹52.96B and high is ₹52.96B.

What is Ajanta Pharma Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 15.58% in 2026-2027.

We have gathered data from 10 analysts. Their low earnings per share estimate is $75.4, average is $87.67 and high is ₹95.6.